M Guembe1, M J Pérez-Granda2, J A Capdevila3, J Barberán4, B Pinilla5, P Martín-Rabadán6, E Bouza7. 1. Department of Clinical Microbiology and Infectious Diseases, HGU Gregorio Marañón, Madrid, Spain. Electronic address: mariaguembe@hotmail.com. 2. Cardiac Surgery Postoperative Care Unit, HGU Gregorio Marañón, Madrid, Spain; CIBER Enfermedades Respiratorias ‒ CIBERES (CB06/06/0058), Madrid, Spain. 3. Department of Internal Medicine, Hospital de Mataró, Barcelona, Spain; Study Group of Infections of the Sociedad Española de Medicina Interna (SEMI), Spain. 4. Department of Internal Medicine, Hospital de Montepríncipe, Madrid, Spain; Study Group of Infections of the Sociedad Española de Medicina Interna (SEMI), Spain. 5. Department of Internal Medicine, HGU Gregorio Marañón, Madrid, Spain. 6. Department of Clinical Microbiology and Infectious Diseases, HGU Gregorio Marañón, Madrid, Spain. 7. Department of Clinical Microbiology and Infectious Diseases, HGU Gregorio Marañón, Madrid, Spain; Medicine Department, School of Medicine, Universidad Complutense de Madrid, Madrid, Spain; Study Group of Infections of the Sociedad Española de Medicina Interna (SEMI), Spain; CIBER Enfermedades Respiratorias ‒ CIBERES (CB06/06/0058), Madrid, Spain.
Abstract
BACKGROUND: The use of intravascular catheters (IVCs) in intensive care units (ICUs) has been well assessed in recent years. However, a high proportion of these devices are placed in patients outside the ICU, particularly in internal medicine departments (IMDs), where data on the quality of care are scarce. AIM: To assess the use and management of IVCs in IMDs in Spain. METHODS: We performed a point prevalence study of all adult inpatients on 47 IMDs from hospitals of different sizes on one day in June 2013. A local co-ordinator was appointed to assess patients and collect data from each site. FINDINGS: Out of the 2080 adult patients hospitalized on the study day, 1703 (81.9%) had one or more IVCs (95.4% of which were peripheral devices). Infection was detected at the insertion site in 92 catheters (5.0%); 87 patients (5.2%) had signs of sepsis, but only one case was considered to be catheter-related. The local co-ordinators estimated that 19% of the catheters in place were no longer necessary. A daily record of the need for a catheter was available in only 40.6% of cases. CONCLUSION: Our study shows clear opportunities for improvement regarding catheter use and care in Spanish IMDs. Strategies similar to those applied in ICUs should be implemented in IMDs.
BACKGROUND: The use of intravascular catheters (IVCs) in intensive care units (ICUs) has been well assessed in recent years. However, a high proportion of these devices are placed in patients outside the ICU, particularly in internal medicine departments (IMDs), where data on the quality of care are scarce. AIM: To assess the use and management of IVCs in IMDs in Spain. METHODS: We performed a point prevalence study of all adult inpatients on 47 IMDs from hospitals of different sizes on one day in June 2013. A local co-ordinator was appointed to assess patients and collect data from each site. FINDINGS: Out of the 2080 adult patients hospitalized on the study day, 1703 (81.9%) had one or more IVCs (95.4% of which were peripheral devices). Infection was detected at the insertion site in 92 catheters (5.0%); 87 patients (5.2%) had signs of sepsis, but only one case was considered to be catheter-related. The local co-ordinators estimated that 19% of the catheters in place were no longer necessary. A daily record of the need for a catheter was available in only 40.6% of cases. CONCLUSION: Our study shows clear opportunities for improvement regarding catheter use and care in Spanish IMDs. Strategies similar to those applied in ICUs should be implemented in IMDs.
Authors: Marco Ripa; Laura Morata; Olga Rodríguez-Núñez; Celia Cardozo; Pedro Puerta-Alcalde; Marta Hernández-Meneses; Juan Ambrosioni; Laura Linares; Marta Bodro; Andrea Valcárcel; Climent Casals; Maria de Los Angeles Guerrero-León; Manel Almela; Carolina Garcia-Vidal; Ana Del Río; Francesc Marco; Josep Mensa; José Antonio Martínez; Alex Soriano Journal: Antimicrob Agents Chemother Date: 2018-10-24 Impact factor: 5.191
Authors: Bart J Laan; Ingrid J B Spijkerman; Mieke H Godfried; Berend C Pasmooij; Jolanda M Maaskant; Marjon J Borgert; Brent C Opmeer; Margreet C Vos; Suzanne E Geerlings Journal: BMC Infect Dis Date: 2017-01-10 Impact factor: 3.090